Literature DB >> 19473701

Inactivation of SHIP1 in T-cell acute lymphoblastic leukemia due to mutation and extensive alternative splicing.

Tony C T Lo1, Lisa M Barnhill, Youngjin Kim, Elizabeth Ann Nakae, Alice L Yu, Mitchell B Diccianni.   

Abstract

To understand the mechanism behind aberrant Akt activation in T-ALL, PIK3CA, PTEN and SHIP1 expression and genotype were assessed. No cell lines or primary ALLs harbored PIK3CA mutations. PTEN was expressed in just one-third of the cell lines, but in two-thirds of the primary ALLs, though in the inactivated (phosphorylated) form. SHIP1 was undetectable in most primary ALL and in the T-ALL cell line Jurkat, which harbored a bi-allelic null mutation and a frame-shift deletion; primary ALL harbored the frame-shift as well as other translationally-inactivating deletions and insertions. The inactivation of SHIP1 could play a central role in the deregulation of Akt pathway and tumorigenesis, perhaps in conjunction with PTEN inactivation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19473701      PMCID: PMC2735879          DOI: 10.1016/j.leukres.2009.04.032

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  11 in total

1.  A cross-talk between oncogenic Ras and tumor suppressor PTEN through FAK Tyr861 phosphorylation in NIH/3T3 mouse embryonic fibroblasts.

Authors:  Young Yil Bahk; Ick-Hyun Cho; Tong Soo Kim
Journal:  Biochem Biophys Res Commun       Date:  2008-11-08       Impact factor: 3.575

2.  Alteration of phosphatidylinositol 3-kinase cascade in the multilobulated nuclear formation of adult T cell leukemia/lymphoma (ATLL).

Authors:  Ryu-ichi Fukuda; Ayako Hayashi; Atae Utsunomiya; Yuko Nukada; Rie Fukui; Katsuhiko Itoh; Katsunari Tezuka; Kazumasa Ohashi; Kensaku Mizuno; Manabu Sakamoto; Masahiro Hamanoue; Takashi Tsuji
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-10       Impact factor: 11.205

3.  Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia.

Authors:  F C von Lintig; I Huvar; P Law; M B Diccianni; A L Yu; G R Boss
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

4.  K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors.

Authors:  Thomas Kindler; Melanie G Cornejo; Claudia Scholl; Jianing Liu; Dena S Leeman; J Erika Haydu; Stefan Fröhling; Benjamin H Lee; D Gary Gilliland
Journal:  Blood       Date:  2008-07-28       Impact factor: 22.113

5.  Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia.

Authors:  Mark Y Chiang; Lanwei Xu; Olga Shestova; Gavin Histen; Sarah L'heureux; Candice Romany; M Eden Childs; Phyllis A Gimotty; Jon C Aster; Warren S Pear
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

6.  Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.

Authors:  S Horn; E Endl; B Fehse; M M Weck; G W Mayr; M Jücker
Journal:  Leukemia       Date:  2004-11       Impact factor: 11.528

Review 7.  Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes.

Authors:  Stephanie J Harris; Richard V Parry; John Westwick; Stephen G Ward
Journal:  J Biol Chem       Date:  2007-12-10       Impact factor: 5.157

8.  T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses.

Authors:  Tatyana Tarasenko; Hemanta K Kole; Anthony W Chi; Margaret M Mentink-Kane; Thomas A Wynn; Silvia Bolland
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-21       Impact factor: 11.205

9.  Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia.

Authors:  J-M Luo; H Yoshida; S Komura; N Ohishi; L Pan; K Shigeno; I Hanamura; K Miura; S Iida; R Ueda; T Naoe; Y Akao; R Ohno; K Ohnishi
Journal:  Leukemia       Date:  2003-01       Impact factor: 11.528

10.  PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability.

Authors:  Ana Silva; J Andrés Yunes; Bruno A Cardoso; Leila R Martins; Patrícia Y Jotta; Miguel Abecasis; Alexandre E Nowill; Nick R Leslie; Angelo A Cardoso; Joao T Barata
Journal:  J Clin Invest       Date:  2008-10-01       Impact factor: 14.808

View more
  9 in total

Review 1.  Macrophage polarization: the link between inflammation and related diseases.

Authors:  Samina Bashir; Yadhu Sharma; Asif Elahi; Farah Khan
Journal:  Inflamm Res       Date:  2016-01       Impact factor: 4.575

Review 2.  Inhibitor and activator: dual functions for SHIP in immunity and cancer.

Authors:  William G Kerr
Journal:  Ann N Y Acad Sci       Date:  2010-12-13       Impact factor: 5.691

3.  NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML.

Authors:  Sophia Adamia; Michal Bar-Natan; Benjamin Haibe-Kains; Patrick M Pilarski; Christian Bach; Samuel Pevzner; Teresa Calimeri; Herve Avet-Loiseau; Laurence Lode; Sigitas Verselis; Edward A Fox; Ilene Galinsky; Steven Mathews; Ibiayi Dagogo-Jack; Martha Wadleigh; David P Steensma; Gabriela Motyckova; Daniel J Deangelo; John Quackenbush; Daniel G Tenen; Richard M Stone; James D Griffin
Journal:  Blood       Date:  2014-02-26       Impact factor: 22.113

4.  Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function.

Authors:  Shari Pilon-Thomas; Nadine Nelson; Nasreen Vohra; Maya Jerald; Laura Pendleton; Karoly Szekeres; Tomar Ghansah
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

5.  Structural basis for interdomain communication in SHIP2 providing high phosphatase activity.

Authors:  Johanne Le Coq; Marta Camacho-Artacho; José Vicente Velázquez; Clara M Santiveri; Luis Heredia Gallego; Ramón Campos-Olivas; Nicole Dölker; Daniel Lietha
Journal:  Elife       Date:  2017-08-09       Impact factor: 8.140

6.  A genome-wide survey of mutations in the Jurkat cell line.

Authors:  Louis Gioia; Azeem Siddique; Steven R Head; Daniel R Salomon; Andrew I Su
Journal:  BMC Genomics       Date:  2018-05-08       Impact factor: 3.969

7.  PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2.

Authors:  Xiaozheng Xu; Bowen Hou; Amitkumar Fulzele; Takeya Masubuchi; Yunlong Zhao; Zijun Wu; Yanyan Hu; Yong Jiang; Yanzhe Ma; Haopeng Wang; Eric J Bennett; Guo Fu; Enfu Hui
Journal:  J Cell Biol       Date:  2020-06-01       Impact factor: 10.539

8.  Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia.

Authors:  Veronika Ecker; Martina Stumpf; Lisa Brandmeier; Tanja Neumayer; Lisa Pfeuffer; Thomas Engleitner; Ingo Ringshausen; Nina Nelson; Manfred Jücker; Stefan Wanninger; Thorsten Zenz; Clemens Wendtner; Katrin Manske; Katja Steiger; Roland Rad; Markus Müschen; Jürgen Ruland; Maike Buchner
Journal:  Nat Commun       Date:  2021-06-10       Impact factor: 14.919

Review 9.  Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment.

Authors:  Alberto M Martelli; Francesca Chiarini; Camilla Evangelisti; Alessandra Cappellini; Francesca Buontempo; Daniela Bressanin; Milena Fini; James A McCubrey
Journal:  Oncotarget       Date:  2012-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.